Inhaled Tobramycin Effectively Reduces FEV(1) Decline in Cystic Fibrosis. An Instrumental Variables Analysis

Rationale: The efficacy of inhaled tobramycin on chronic Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF) has been established in clinical trials. However, little is known about its clinical effectiveness on lung function outside randomized controlled trial settings; conventio...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Am Thorac Soc
Asıl Yazarlar: VanDyke, Rhonda D., McPhail, Gary L., Huang, Bin, Fenchel, Matthew C., Amin, Raouf S., Carle, Adam C., Chini, Barb A., Seid, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Thoracic Society 2013
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475429/
https://ncbi.nlm.nih.gov/pubmed/23802816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201209-082OC
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller